We use cookies on this website. By using the website you accept our use of cookies. Accept

Novo A/S

Novo A/S was established in 1999 and is fully owned by the Novo Nordisk Foundation, an independent Danish foundation with corporate interests and a history going back to 1923.

Novo A/S oversees, invests and manages the assets of the Novo Nordisk Foundation valued at more than EUR 47 billion.

Besides being the controlling shareholder in the Novo Group companies, including Novo Nordisk A/S and Novozymes A/S, Novo A/S provides seed and venture capital to development stage companies and takes significant ownership positions in well-established companies within life science, as well as manages a broad portfolio of financial assets.

As an international investor, we work out of Copenhagen, San Francisco, Boston and London. Our team of scientific and commercial experts actively support our portfolio of projects and companies and manage our range of financial investments.

 

”It is our ambition to become recognized as a world leading life science investor”

Kasim Kutay, CEO, Novo A/S

Bringing promising ideas to life…

Novo is one of the key players in the international life science investment industry, and is currently investing in 76 portfolio companies.

Our portfolio spans the entire range of life science development. From budding ideas, that need financial and commercial nurturing, to well-established biomedical and bioindustrial companies that call for significant capital and a long term investor to accelerate growth.

 

… through long-term commitment

We are actively involved in our portfolio companies and have the financial strength to stay the course. Our partners have a background in life science and in addition to financial backing, we are able to provide the managerial, commercial and strategic support the project or company needs to develop to the next stage.

… to dedicated people with great ideas.

But it takes more than committed support and excellent research to bring innovative solutions to market. It takes skilled scientists and resourceful entrepreneurs who know how to transform strong results into marketable products. We’re privileged to work with these teams of dedicated individuals whose solutions promote better healthcare for people all over the world.